Friday, September 30, 2016

Quintex




In the US, Quintex (guaifenesin/phenylephrine/phenylpropanolamine systemic) is a member of the drug class upper respiratory combinations and is used to treat Cough and Nasal Congestion and Sinus Symptoms.

US matches:

  • Quintex

Ingredient matches for Quintex



Butamirate

Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of Quintex in the following countries:


  • Luxembourg

International Drug Name Search


Dimetikon Meda




Dimetikon Meda may be available in the countries listed below.


Ingredient matches for Dimetikon Meda



Simeticone

Simeticone is reported as an ingredient of Dimetikon Meda in the following countries:


  • Sweden

International Drug Name Search


Synax




Synax may be available in the countries listed below.


Ingredient matches for Synax



Naproxen

Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Synax in the following countries:


  • Turkey

International Drug Name Search


Depakene


Depakene is a brand name of valproic acid, approved by the FDA in the following formulation(s):


DEPAKENE (valproic acid - capsule; oral)



  • Manufacturer: ABBOTT

    Approved Prior to Jan 1, 1982

    Strength(s): 250MG [RLD][AB]

DEPAKENE (valproic acid - syrup; oral)



  • Manufacturer: ABBOTT

    Approved Prior to Jan 1, 1982

    Strength(s): 250MG/5ML [RLD][AA]

Has a generic version of Depakene been approved?


Yes. The following products are equivalent to Depakene:


valproic acid capsule; oral



  • Manufacturer: BANNER PHARMACAPS

    Approval date: June 29, 1993

    Strength(s): 250MG [AB]


  • Manufacturer: CATALENT

    Approval date: October 29, 1991

    Strength(s): 250MG [AB]

valproic acid syrup; oral



  • Manufacturer: ALPHARMA

    Approval date: December 22, 2000

    Strength(s): 250MG/5ML [AA]


  • Manufacturer: HIGH TECH PHARMA

    Approval date: January 13, 1995

    Strength(s): 250MG/5ML [AA]


  • Manufacturer: PHARM ASSOC

    Approval date: December 15, 2000

    Strength(s): 250MG/5ML [AA]


  • Manufacturer: SUN PHARM INDS INC

    Approval date: May 28, 2010

    Strength(s): 250MG/5ML [AA]


  • Manufacturer: TEVA PHARMS

    Approval date: August 25, 1992

    Strength(s): 250MG/5ML [AA]


  • Manufacturer: VINTAGE

    Approval date: October 13, 2006

    Strength(s): 250MG/5ML [AA]


  • Manufacturer: WOCKHARDT

    Approval date: July 1, 1986

    Strength(s): 250MG/5ML [AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Depakene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Depakene.

See also...

  • Depakene Consumer Information (Wolters Kluwer)
  • Depakene Syrup Consumer Information (Wolters Kluwer)
  • Depakene Consumer Information (Cerner Multum)
  • Depakene Advanced Consumer Information (Micromedex)
  • Valproate Consumer Information (Wolters Kluwer)
  • Valproate Syrup Consumer Information (Wolters Kluwer)
  • Valproic Acid Consumer Information (Wolters Kluwer)
  • Valproic Acid Delayed-Release Capsules Consumer Information (Wolters Kluwer)
  • Valproic Acid Syrup Consumer Information (Wolters Kluwer)
  • Valproic acid Consumer Information (Cerner Multum)
  • Alti-Valproic Advanced Consumer Information (Micromedex)
  • Depakote Advanced Consumer Information (Micromedex)
  • Depakote DR Advanced Consumer Information (Micromedex)
  • Depakote ER Advanced Consumer Information (Micromedex)
  • Depakote Sprinkles Advanced Consumer Information (Micromedex)
  • Epiject Iv Advanced Consumer Information (Micromedex)
  • Valproate sodium Intravenous Advanced Consumer Information (Micromedex)
  • Valproic acid Advanced Consumer Information (Micromedex)

Cushing's Syndrome Medications


Definition of Cushing's Syndrome: An increased concentration of glucocorticoid hormone

Drugs associated with Cushing's Syndrome

The following drugs and medications are in some way related to, or used in the treatment of Cushing's Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Cushing's Syndrome





Drug List: